CClinicalTrials.gg
CompletedNCT02743312TWPSUpdated Nov 6, 2018Results posted

Long-Term Effects of Torso-Weighting

An interventional study of Torso Weights and Sham Weights in Multiple Sclerosis, sponsored by San Francisco State University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-06.

Sponsored by San Francisco State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this pilot study is to test the protocol for investigating the longer-term effects of torso weighting on physical activity, number of falls, and muscle activation (when muscles turn on and off and how intensely) in five volunteers with multiple sclerosis. The hypotheses of this study include: torso weighting will (1) increase physical activity, (2) decrease the number of falls, and (3) improve the timing and coordination of muscle activation during balance perturbations.

Read the detailed description

Torso weighting, using the balance-based torso-weighting (BBTW) method, is an intervention that addresses balance by first challenging stability in standing using a series of perturbations (nudges) and resisted rotations to people. Challenging stability allows the assessor to determine directional instability. Once the direction of instability is determined, small weights are placed on a vest-like garment and retesting of balance occurs. In this study, participants will be tested with no weights (NW), with sham weights (SW), and with BBTW weighting (WT). Following non-weighted baseline assessment, participants will be randomly allocated into the sham weight condition or BBTW weight condition in a cross-over design. The initial condition (NW) will last four weeks and the final two conditions (SW,WT) will last two weeks each. Following each condition, outcome measures will be reassessed. Throughout the study, participants will be asked to wear a commercially-available remote monitoring device (e.g., Fitbit Flex) and keep a daily log of physical activity and number of falls. During the SW and WT conditions, participants will wear the assigned garment for 2-4 hours daily.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • Balance-Based Torso-Weighting
  • Physical Activity
  • Neurorehabilitation
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 660 are open to participants now.

This study's enrollment of 5 is below the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

San Francisco State University is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Self-reported a diagnosis of multiple sclerosis
  • Self-reported mild or moderate gait or balance difficulties
  • Living in the community rather than in a care facility
  • Able to walk independently for at least one minute at a time with or without an assistive device
  • No exacerbations within the past 2 months
  • Able to get to the testing area and tolerate 2-3 hours of testing for each assessment occasion
  • Willing to be nudged by a researcher when standing

Exclusion criteria

Exclusion Criteria:

  • Unable to comprehend and follow instructions in English
  • Current diagnosis of other neurological disorders such as head injury, stroke, Parkinson disease, or other conditions that affect gait or balance (self-reported)
  • Experiencing pain that could be exacerbated by external perturbation while standing
  • History of skin reaction to adhesives
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Torso Weights then Sham Weights

    No weights worn for 4 weeks. Garment with torso weights worn 2-4 hours daily for 2 weeks. Then participants cross-over to wear garment with sham weights for 2-4 hours daily for 2 weeks. Participants wear the Fitbit Flex throughout.

    Device: Torso Weights · Device: Sham Weights · Device: Fitbit Flex

  • Experimental
    Sham Weights then Torso Weights

    No weights worn for 4 weeks. Garment with sham weights worn 2-4 hours daily for 2 weeks. Then participants cross-over to wear garment with torso weights for 2-4 hours daily for 2 weeks. Participants wear the Fitbit Flex throughout.

    Device: Torso Weights · Device: Sham Weights · Device: Fitbit Flex

Interventions

  • DeviceTorso Weights

    Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.

    Also known as: WT

  • DeviceSham Weights

    Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss. The garment is then taken by another investigator and the actual weights are replaced with sham weights.

    Also known as: SW

  • DeviceFitbit Flex

    Potential effect on participants' physical activity to see their own step count using this wrist-worn remote monitoring device.

    Also known as: remote activity monitoring device

06

What researchers measure

Primary outcomes

  1. Steps Per Day

    Continuous activity data collection via commercially-available remote monitoring device and stored on server.

    Time frame: up to 8 weeks

Secondary outcomes

  1. Sensory Organization Test

    balance tested during 6 conditions on Neuro-com forceplate and surround and reported as a composite score (across the six conditions), 0-100, with higher scores indicating better balance; measure reported reflects change in the composite score from the visit that initiates Torso-weighting (TW) or sham weights (SW) to the visit that concludes daily wearing of TW or SW

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  2. Gait Velocity

    As measured using instrumented gait mat.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  3. Movement Ability Measure, Computer Adaptive Test Version (MAM-CAT)

    Online self-report of perceived current movement ability and preferred movement ability. The scores are reported in standardized logits, 0-6, where 6 is competitive level athletic movement. The reported values are the average change in current movement ability from initiation of daily wear to after 2 weeks of daily wear of TW or SW.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  4. Activities-Specific Balance Confidence Scale

    Self-report measure of perception of confidence under various balance challenges on a scale of 0-100 with 100 being fully confident that the individual can perform the listed balance challenge without falling. Data reported reflect the difference in scores from initiation to the 2-week point after initiation of TW or SW.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  5. Multiple Sclerosis Impact Scale 29

    Self-report measure of the impact of MS on activities and participation. The scale is reported in a physical and psychological subscale, with higher numbers (out of 100) indicating worse impact of multiple sclerosis (MS) on function. Data are reported as change from initiation of TW or SW to end of 2 weeks of daily wear.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  6. Multiple Sclerosis Walking Scale 12

    Self-report measure of the effect of MS on walking ability. Larger numbers out of 100 mean that MS limits walking much more. Data are reported as change in score from initiation of TW or SW to the visit after 2 weeks of daily wear of TW or SW.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  7. Six-Minute Walk Test

    distance participant walks in 6 minutes. Larger numbers indicate more distance covered. Data reported are the change in distance walked from initiation of TW or SW to after 2 weeks of daily wear.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  8. Stride Length

    As measured using instrumented gait mat.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  9. Percent of Gait Cycle in Single Limb Support

    As measured in percent (e.g., 0.35) of gait cycle spent on one limb using instrumented gait mat.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  10. Step Width

    As measured using instrumented gait mat.

    Time frame: change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  11. Electromyography to Assess Muscle Activation

    Recording of muscle activation during quiet and perturbed standing before and after intervention at weeks 4, 6, and 8. Average values with and without weighting during each visit.

    Time frame: Week 4, Week 6, Week 8

  12. Number of Falls Recorded in 2 Weeks of Wear Time.

    Daily log manually recorded by participant for the 2 weeks of wear time. This is a descriptive measure recording the total count (number) of falls per arm.

    Time frame: count of number of falls recorded at the end of two weeks of wearing TW or SW

07

Results

Posted Nov 6, 2018

Participant flow

5 volunteers were screened for eligibility from November 1, 2015, to April 1, 2016.

Participant flow — Overall Study
MilestoneTorso Weights Then Sham WeightsSham Weights Then Torso Weights
Started32
Completed32
Not completed00

Outcome measures

PrimarySteps Per Day

Continuous activity data collection via commercially-available remote monitoring device and stored on server.

Time frame:
up to 8 weeks

No measurements were reported for this outcome.

SecondarySensory Organization Test

balance tested during 6 conditions on Neuro-com forceplate and surround and reported as a composite score (across the six conditions), 0-100, with higher scores indicating better balance; measure reported reflects change in the composite score from the visit that initiates Torso-weighting (TW) or sham weights (SW) to the visit that concludes daily wearing of TW or SW

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · scores on a scale
Sensory Organization Test
scores on a scaleTorso WeightsSham Weights
Sensory Organization Test7.4 ± 8.41 ± 9.7
SecondaryGait Velocity

As measured using instrumented gait mat.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · meters/second
Gait Velocity
meters/secondTorso WeightsSham Weights
Gait Velocity.125 ± .14-.03 ± .14
SecondaryMovement Ability Measure, Computer Adaptive Test Version (MAM-CAT)

Online self-report of perceived current movement ability and preferred movement ability. The scores are reported in standardized logits, 0-6, where 6 is competitive level athletic movement. The reported values are the average change in current movement ability from initiation of daily wear to after 2 weeks of daily wear of TW or SW.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · units on a scale
Movement Ability Measure, Computer Adaptive Test Version (MAM-CAT)
units on a scaleTorso WeightsSham Weights
Movement Ability Measure, Computer Adaptive Test Version (MAM-CAT).36 ± 1.8.3 ± .7
SecondaryActivities-Specific Balance Confidence Scale

Self-report measure of perception of confidence under various balance challenges on a scale of 0-100 with 100 being fully confident that the individual can perform the listed balance challenge without falling. Data reported reflect the difference in scores from initiation to the 2-week point after initiation of TW or SW.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · units on a scale
Activities-Specific Balance Confidence Scale
units on a scaleTorso WeightsSham Weights
Activities-Specific Balance Confidence Scale1.5 ± 6.63 ± 6.9
SecondaryMultiple Sclerosis Impact Scale 29

Self-report measure of the impact of MS on activities and participation. The scale is reported in a physical and psychological subscale, with higher numbers (out of 100) indicating worse impact of multiple sclerosis (MS) on function. Data are reported as change from initiation of TW or SW to end of 2 weeks of daily wear.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · units on a scale
Multiple Sclerosis Impact Scale 29
units on a scaleTorso WeightsSham Weights
Physical score-6.7 ± 4.7-5.25 ± 10.5
Psychological score-4.4 ± 12.2-6.1 ± 10.3
SecondaryMultiple Sclerosis Walking Scale 12

Self-report measure of the effect of MS on walking ability. Larger numbers out of 100 mean that MS limits walking much more. Data are reported as change in score from initiation of TW or SW to the visit after 2 weeks of daily wear of TW or SW.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · units on a scale
Multiple Sclerosis Walking Scale 12
units on a scaleTorso WeightsSham Weights
Multiple Sclerosis Walking Scale 12-7.9 ± 9.6-0.8 ± 13.3
SecondarySix-Minute Walk Test

distance participant walks in 6 minutes. Larger numbers indicate more distance covered. Data reported are the change in distance walked from initiation of TW or SW to after 2 weeks of daily wear.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · meters walked
Six-Minute Walk Test
meters walkedTorso WeightsSham Weights
Six-Minute Walk Test47.4 ± 52-19 ± 44.3
SecondaryStride Length

As measured using instrumented gait mat.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · meters
Stride Length
metersTorso WeightsSham Weights
Stride Length.09 ± .09-.02 ± .11
SecondaryPercent of Gait Cycle in Single Limb Support

As measured in percent (e.g., 0.35) of gait cycle spent on one limb using instrumented gait mat.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · percentage of gait cycle on one limb
Percent of Gait Cycle in Single Limb Support
percentage of gait cycle on one limbTorso WeightsSham Weights
Percent of Gait Cycle in Single Limb Support.0067 ± .0062-.0026 ± .0072
SecondaryStep Width

As measured using instrumented gait mat.

Time frame:
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Reported as:
Mean · meters
Step Width
metersTorso WeightsSham Weights
Step Width-.0084 ± .03.014 ± .014
SecondaryElectromyography to Assess Muscle Activation

Recording of muscle activation during quiet and perturbed standing before and after intervention at weeks 4, 6, and 8. Average values with and without weighting during each visit.

Time frame:
Week 4, Week 6, Week 8

No measurements were reported for this outcome.

SecondaryNumber of Falls Recorded in 2 Weeks of Wear Time.

Daily log manually recorded by participant for the 2 weeks of wear time. This is a descriptive measure recording the total count (number) of falls per arm.

Time frame:
count of number of falls recorded at the end of two weeks of wearing TW or SW
Reported as:
Number · falls
Number of Falls Recorded in 2 Weeks of Wear Time.
fallsTorso WeightsSham Weights
Number of Falls Recorded in 2 Weeks of Wear Time.01

Adverse events

Collected over 6 months, beginning to end of data collection of any participant. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Torso Weights0/5 (0%)0/5 (0%)0/5 (0%)
Sham Weights0/5 (0%)0/5 (0%)0/5 (0%)
Pre-weighting (no Weights)0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Torso Weights Then Sham WeightsSham Weights Then Torso WeightsTotal
<=18 years000
Between 18 and 65 years314
>=65 years011
Sex: Female, Male
Sex: Female, Male(Participants)Torso Weights Then Sham WeightsSham Weights Then Torso WeightsTotal
Female224
Male101
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Torso Weights Then Sham WeightsSham Weights Then Torso WeightsTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(Participants)Torso Weights Then Sham WeightsSham Weights Then Torso WeightsTotal
United States325
08

Study locations

1 site
  • Samuel Merritt University, Motion Analysis Research Center
    Oakland, California 94609, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02743312
Lead sponsor
San Francisco State University
Collaborators
Samuel Merritt University
Responsible party
Sponsor
First posted
Apr 19, 2016
Start date
Nov 2015
Primary completion
May 2016
Completion
Jun 2016
Results posted
Nov 6, 2018
Last update
Nov 6, 2018

Study contacts

Diane Allen, PhD
principal investigator · San Francisco State University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion